期刊文献+
共找到1,153篇文章
< 1 2 58 >
每页显示 20 50 100
A clinical analysis of risk factor with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis Esophagectomy
1
作者 孙志钢 《外科研究与新技术》 2011年第3期165-165,共1页
Objective To investigate the risk factors with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis Esophagectomy. Methods The subjects were 82 patients with pN0 esophagea cancer who... Objective To investigate the risk factors with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis Esophagectomy. Methods The subjects were 82 patients with pN0 esophagea cancer who underwent Ivor-Lewis esophagectomy from January 2001 to January 2005. By using RT-PCR,VEGF C mRNA was detected in tumor issues,and Mucin (MUC1) mRNA was detected in lymph nodes. The Kaplan-Meier method was used to calculate the survival 展开更多
关键词 Ivor A clinical analysis of risk factor with lymph node metastatic recurrence in patients with N0 esophageal cancer after ivor-lewis esophagectomy node
下载PDF
Influencing factors of postoperative early delayed gastric emptying after minimally invasive Ivor-Lewis esophagectomy 被引量:2
2
作者 Lei Huang Jian-Qiang Wu +5 位作者 Bing Han Zhi Wen Pei-Rui Chen Xiao-Kang Sun Xiang-Dong Guo Chang-Ming Zhao 《World Journal of Clinical Cases》 SCIE 2019年第3期291-299,共9页
BACKGROUND The main clinical treatment for esophageal cancer is surgery. Since traditional open esophageal cancer resection has the disadvantages of large trauma, long recovery period, and high postoperative complicat... BACKGROUND The main clinical treatment for esophageal cancer is surgery. Since traditional open esophageal cancer resection has the disadvantages of large trauma, long recovery period, and high postoperative complication rate, its clinical application is gradually reduced. The current report of minimally invasive Ivor-Lewis esophagectomy(MIILE) is increasing. However, researchers found that patients with MIILE had a higher incidence of early delayed gastric emptying(DGE).AIM To investigate the influencing factors of postoperative early DGE after MIILE.METHODS A total of 156 patients diagnosed with esophageal cancer at Deyang People's Hospital were enrolled. According to the criteria of DGE, patients were assigned to a DGE group(n = 49) and a control group(n = 107). The differences between the DGE group and the control group were compared. Multivariate logistic regression analysis was used to further determine the influencing factors of postoperative early DGE. The receiver operating characteristic(ROC) curve was used to assess potential factors in predicting postoperative early DGE.RESULTS Age, intraoperative blood loss, chest drainage time, portion of anxiety score ≥ 45 points, analgesia pump use, postoperative to enteral nutrition interval, and postoperative fluid volume in the DGE group were higher than those in the control group. Perioperative albumin level in the DGE group was lower than that in the control group(P < 0.05). Age, anxiety score, perioperative albumin level,and postoperative fluid volume were independent factors influencing postoperative early DGE, and the differences were statistically significant(P <0.05). The ROC curve analysis revealed that the area under the curve(AUC) foranxiety score was 0.720. The optimum cut-off value was 39, and the sensitivity and specificity were 80.37% and 65.31%, respectively. The AUC for postoperative fluid volume were 0.774. The optimal cut-off value was 1191.86 mL, and the sensitivity and specificity were 65.3% and 77.6%, respectively. The AUC for perioperative albumin level was 0.758. The optimum cut-off value was 26.75 g/L,and the sensitivity and specificity were 97.2% and 46.9%, respectively.CONCLUSION Advanced age, postoperative anxiety, perioperative albumin level, and postoperative fluid volume can increase the incidence of postoperative early DGE. 展开更多
关键词 Esophageal cancer Delayed gastric EMPTYING MINIMALLY INVASIVE ivor-lewis esophagectomy Influencing factors
下载PDF
Two-step method for creating a gastric tube during laparoscopic-thoracoscopic Ivor-Lewis esophagectomy 被引量:5
3
作者 yu liu ji-jia li +3 位作者 peng zu hong-xu liu zhan-wu yu yi ren 《World Journal of Gastroenterology》 SCIE CAS 2017年第45期8035-8043,共9页
AIM To introduce a two-step method for creating a gastric tube during laparoscopic-thoracoscopic Ivor-Lewis esophagectomy and assess its clinical application.METHODS One hundred and twenty-two patients with middle or ... AIM To introduce a two-step method for creating a gastric tube during laparoscopic-thoracoscopic Ivor-Lewis esophagectomy and assess its clinical application.METHODS One hundred and twenty-two patients with middle or lower esophageal cancer who underwent laparoscopicthoracoscopic Ivor-Lewis esophagectomy at Liaoning Cancer Hospital and Institute from March 2014 to March 2016 were included in this study,and divided into two groups based on the procedure used for creating a gastric tube. One group used a two-step method for creating a gastric tube,and the other group used the conventional method. The two groups were compared regarding the operating time,surgical complications,and number of stapler cartridges used.RESULTS The mean operating time was significantly shorter in the two-step method group than in the conventional method group [238(179-293) min vs 272(189-347) min,P < 0.01]. No postoperative death occurred in either group. There was no significant difference in the rate of complications [14(21.9%) vs 13(22.4%),P= 0.55] or mean number of stapler cartridges used [5(4-6) vs 5.2(5-6),P = 0.007] between the two groups.CONCLUSION The two-step method for creating a gastric tube during laparoscopic-thoracoscopic Ivor-Lewis esophagectomy has the advantages of simple operation,minimal damage to the tubular stomach,and reduced use of stapler cartridges. 展开更多
关键词 最低限度地侵略的 srugery 胃的试管 Ivor 吊楔 esophagectomy
下载PDF
Comparison of the surgical outcomes of McKeown minimally invasive esophagectomy and Ivor-Lewis esophagectomy for the treatment of middle esophageal cancer:A single-center retrospective study 被引量:1
4
作者 Raojun Luo Zhengfu He +1 位作者 Yong Xu Ziyi Zhu 《Laparoscopic, Endoscopic and Robotic Surgery》 2020年第1期12-16,共5页
Background:In China,the esophageal cancer is the most common tumor type,and the main treatment is still surgical treatment.Over the past decade,thoracic laparoscopy combined with esophageal cancer resection and neck a... Background:In China,the esophageal cancer is the most common tumor type,and the main treatment is still surgical treatment.Over the past decade,thoracic laparoscopy combined with esophageal cancer resection and neck anastomosis-McKeown minimally invasive esophagectomy(MIE)has gained interest and known as a minimally invasive surgery for the middle esophageal cancer.However,the safety and operability of McKeown MIE remains to be confirmed clinically.The purpose of this article is to examine the clinical safety and operability of McKeown MIE,and compare the security and outcomes of McKeown MIE and Ivor-Lewis esophagectomy.Materials and methods:The clinical data of 312 patients with middle esophageal cancer in Sir Run Run Shaw Hospital from January 2013 to December 2018 were retrospectively analyzed.Among them,176 patients underwent Ivor-Lewis esophagectomy and 136 patients underwent McKeown MIE.Patients'demographics and perioperative outcomes were comparable between the two groups.Results:There were no significant differences in terms of operative time,postoperative hospital stay,restore fluid diet time,pathology,tumor node metastasis staging between the two groups.In the McKeown MIE group,the intraoperative blood loss was less than that in the Ivor-Lewis group(116.54±80.99 ml vs 152.78±115.35 ml,p=0.001).The total number of lymph nodes and the number of lymph nodes dissection in bilateral recurrent laryngeal nerves were more than those in the Ivor-Lewis group(30.04±14.08 vs 27.51±11.34,p=0.039;5.74±4.27 vs 1.80±2.68,p<0.001).There were no significant differences in the incidence of complications.The overall survival for the McKeown MIE group was higher than the Ivor-Lewis group(p=0.013)and no significant difference was found on disease-free survival.Conclusion:McKeown MIE is safe and operational for middle esophageal cancer,which is consistent with the principle of tumor radicalization. 展开更多
关键词 Middle esophageal cancer Minimally invasive esophagectomy Lymph node dissection
下载PDF
Gastrointestinal function testing model using a new laryngopharyngeal pH probe(Restech)in patients after Ivor-Lewis esophagectomy
5
作者 Benjamin Babic Dolores T Müller +6 位作者 Florian Gebauer Lars Mortimer Schiffmann Rabi R Datta WolfgangSchröder Christiane J Bruns Jessica M Leers Hans F Fuchs 《World Journal of Gastrointestinal Oncology》 SCIE 2021年第6期612-624,共13页
BACKGROUND There is no established correlation between 24-h esophageal pH-metry(Eso-pH)and the new laryngopharyngeal pH-monitoring system(Restech)as only small case series exist.Eso-pH was not designed to detect laryn... BACKGROUND There is no established correlation between 24-h esophageal pH-metry(Eso-pH)and the new laryngopharyngeal pH-monitoring system(Restech)as only small case series exist.Eso-pH was not designed to detect laryngopharyngeal reflux(LPR)and Restech may detect LPR better.We have previously published a dataset using the two techniques in a large patient collective with gastroesophageal reflux disease.Anatomically,patients after esophagectomy were reported to represent an ideal human reflux model as no reflux barrier exists.AIM To use a human reflux model to examine our previously published correlation in these patients.METHODS Patients after Ivor Lewis esophagectomy underwent our routine follow-up program with surveillance endoscopies,computed tomography scans and further exams following surgery.Only patients with a complete check-up program and reflux symptoms were offered inclusion into this prospective study and evaluated using Restech and simultaneous Eso-pH.Subsequently,the relationship between the two techniques was evaluated RESULTS A total of 43 patients from May 2016-November 2018 were included.All patients presented with mainly typical reflux symptoms such as heartburn(74%),regurgitation(84%),chest pain(58%),and dysphagia(47%).Extraesophageal symptoms such as cough,hoarseness,asthma symptoms,and globus sensation were also present.Esophageal 24-hour pH-metry was abnormal in 88%of patients with a mean DeMeester Score of 229.45[range 26.4-319.5].Restech evaluation was abnormal in 61%of cases in this highly selective patient cohort.All patients with abnormal supine LPR were also abnormal for supine esophageal reflux measured by conventional Eso-pH.CONCLUSION Patients following esophagectomy and reconstruction with gastric interposition can ideally serve as a human reflux model.Interestingly,laryngopharyngeal reflux phases occur mainly in the upright position.In this human volume-reflux model,results of simultaneous esophageal and laryngopharyngeal(Restech)pHmetry showed 100%correlation as being explicable by one of our reflux scenarios. 展开更多
关键词 Gastroesophageal reflux disease Laryngopharyngeal reflux Minimally invasive esophagectomy Surgical technology Restech Esophageal pH-metry
下载PDF
食管癌微创和开放Ivor-Lewis术的效果分析 被引量:2
6
作者 姚杰 程元骏 +2 位作者 张友明 臧国辉 田界勇 《皖南医学院学报》 CAS 2023年第2期130-133,共4页
目的:探讨微创食管切除术(MIE Ivor-Lewis)与开放食管切除术(OE Ivor-Lewis)治疗食管癌的安全性、可行性和短期结果。方法:回顾性分析2018年5月~2021年12月接受MIE Ivor-Lewis或OE Ivor-Lewis治疗的食管癌患者的临床和手术资料。比较两... 目的:探讨微创食管切除术(MIE Ivor-Lewis)与开放食管切除术(OE Ivor-Lewis)治疗食管癌的安全性、可行性和短期结果。方法:回顾性分析2018年5月~2021年12月接受MIE Ivor-Lewis或OE Ivor-Lewis治疗的食管癌患者的临床和手术资料。比较两组患者的基础特征、病理资料、手术方式、围手术期结果和生存率。结果:54例患者90 d内无1例死亡。32例接受MIE Ivor-Lewis治疗,22例接受OE Ivor-Lewis治疗。与OE组比较,MIE组手术时间长(P<0.05),清扫淋巴结数量多(P<0.05),肺部并发症、吻合口狭窄发生率低(P<0.05)。结论:与OE相比,MIE治疗食管癌在围手术期结局方面具有优势,并发症少。 展开更多
关键词 食管癌 食管切除术 胸腹腔镜 ivor-lewis 术后并发症
下载PDF
ERAS模式在Ivor-Lewis联合空肠造瘘术在下段食管癌中应用的临床观察 被引量:3
7
作者 刘超 韩志锋 +1 位作者 王志宁 陈亮 《临床肿瘤学杂志》 CAS 2023年第2期151-154,共4页
目的 分析ERAS模式在Ivor-Lewis联合空肠造瘘术治疗中下段食管癌效果。方法 选取我院2015年12月至2021年10月收治的117例中下段食管癌患者的临床资料。患者均接受Ivor-Lewis联合空肠造瘘术治疗。随机数字表法分为常规组(n=58,常规模式)... 目的 分析ERAS模式在Ivor-Lewis联合空肠造瘘术治疗中下段食管癌效果。方法 选取我院2015年12月至2021年10月收治的117例中下段食管癌患者的临床资料。患者均接受Ivor-Lewis联合空肠造瘘术治疗。随机数字表法分为常规组(n=58,常规模式)与ERAS组(n=59,ERAS模式)。比较两组术中与术后指标、应激指标、生活质量及并发症。结果 ERAS组胃肠功能恢复时间、住院时间、引流管留置时间及肛门排气时间均短于常规组,术中出血量少于常规组(P<0.05)。术后,两组应激指标CRP、TNF-α及IL-6水平均较术前增高,ERAS组应激指标水平均低于常规组(P<0.05)。术后,两组EORTCQLQ-C30量表躯体、情绪、角色、认知、社会功能及总体健康评分均较术前增高,且ERAS组上述评分均高于常规组(P<0.05)。ERAS组并发症总发生率为15.25%,常规组并发症总发生率为20.69%,组间差异无统计学意义(P>0.05)。结论 在空肠造瘘术联合Ivor-Lewis术治疗中下段食管癌中采用ERAS模式可改善患者生活质量,减轻其应激反应,促进患者康复。 展开更多
关键词 中下段食管癌 加速康复外科模式 ivor-lewis 空肠造瘘术
下载PDF
经上腹左胸手术和Ivor-lewis手术治疗SiewertⅡ型食管胃交界部腺癌的疗效比较 被引量:1
8
作者 李飞 宋媛 +1 位作者 岳泓旭 贺淼 《现代肿瘤医学》 CAS 北大核心 2023年第2期272-277,共6页
目的:对比经上腹左胸手术和Ivor-lewis手术治疗SiewertⅡ型食管胃交界部腺癌(adenocarcinoma of the esophagogastric junction,AEG)在术中和术后各参数中的差别,以及患者预后的差异。方法:回顾性收集320例于河北医科大学第四医院胸外... 目的:对比经上腹左胸手术和Ivor-lewis手术治疗SiewertⅡ型食管胃交界部腺癌(adenocarcinoma of the esophagogastric junction,AEG)在术中和术后各参数中的差别,以及患者预后的差异。方法:回顾性收集320例于河北医科大学第四医院胸外科行根治性手术的SiewertⅡ型AEG患者的数据,其中行上腹左胸手术的患者175例,行Ivor-lewis手术的患者145例。比较两组患者的临床病理特征、术中和术后情况、总生存时间(overall survival,OS)和无病生存时间(disease-free survival,DFS),并对影响AEG患者预后的情况进行单因素和多因素分析。结果:两组患者在肿瘤最大直径、pTNM分期、pN分期和下残阳性方面比较有统计学差异(P<0.05);与Ivor-lewis手术相比,行上腹左胸手术患者的术中时间缩短了30 min(P=0.034),术后吻合口瘘发生率更低(1.71%vs 4.83%,P=0.041);相比Ivor-lewis患者,行上腹左胸手术的患者可以获得更好的OS和DFS(P<0.05);单因素和多因素分析显示术前新辅助治疗是SiewertⅡ型AEG患者预后的影响因素(P<0.05)。结论:经上腹左胸手术可以彻底切除肿瘤,保留膈肌的完整,缩短开胸时间,有利于术后快速康复。同时,术后吻合口瘘等并发症的发生率低,有利于及时进行术后辅助治疗,更利于改善AEG患者的预后。 展开更多
关键词 食管胃交界部腺癌 SiewertⅡ型 上腹左胸手术 ivor-lewis手术
下载PDF
全腔镜Ivor-Lewis术治疗中下段食管癌效果分析
9
作者 王杰 金哲 李向楠 《河南外科学杂志》 2023年第3期46-48,共3页
目的探讨全腔镜Ivor-Lewis术治疗中下段食管癌(EC)的效果。方法回顾性分析镇平县人民医院2020-01-2022-07行全腔镜手术治疗的96例中下段EC患者的临床资料,分为McKeown组(M组)和Ivor-Lewis组(I组),各49例。比较2组手术指标。手术前后检... 目的探讨全腔镜Ivor-Lewis术治疗中下段食管癌(EC)的效果。方法回顾性分析镇平县人民医院2020-01-2022-07行全腔镜手术治疗的96例中下段EC患者的临床资料,分为McKeown组(M组)和Ivor-Lewis组(I组),各49例。比较2组手术指标。手术前后检测胃泌素(GAS)、胃动素(MTL)胃肠功能指标水平和皮质醇(Cor)、肾上腺素(AD)应激因子水平。统计并发症发生率和随访6个月期间的复发率。结果2组患者的淋巴结清扫数和术后并发症发生率的差异均无统计学意义(P>0.05)。I组术中失血量、手术耗时、胸管留置时长均少于M组,术后血清GAS和MTL水平、Cor和AD水平,以及并发症总发生率均优于M组。以上差异均有统计学意义(P<0.05)。2组患者的复发率差异无统计学意义(P>0.05)。结论全腔镜下Ivor-Lewis术与McKeown术治疗中下段EC患者均有良好效果,但Ivor-Lewis术具有手术耗时及胸管留置时长短、术中出血量少、并发症风险低,以及对机体胃肠功能和应激反应影响小等优势。 展开更多
关键词 食管癌 McKeown术 ivor-lewis
下载PDF
全腔镜Ivor-Lewis术对中下段食管癌患者氧化应激指标、胃肠功能及预后的影响 被引量:1
10
作者 岳军 崔刘涛 +2 位作者 张冲锋 牛瑞玲 徐林飞 《海南医学》 CAS 2023年第9期1250-1254,共5页
目的探讨全腔镜Ivor-Lewis术对中下段食管癌患者氧化应激指标、胃肠功能及预后的影响。方法回顾性分析2019年1月至2022年1月在驻马店市中医院行手术治疗的150例中下段食管癌患者的临床资料,根据手术方式不同分组,其中76例实施全腔镜Ivor... 目的探讨全腔镜Ivor-Lewis术对中下段食管癌患者氧化应激指标、胃肠功能及预后的影响。方法回顾性分析2019年1月至2022年1月在驻马店市中医院行手术治疗的150例中下段食管癌患者的临床资料,根据手术方式不同分组,其中76例实施全腔镜Ivor-Lewis术者纳入研究组,74例实施全腔镜McKeown术者纳入对照组。比较两组患者的手术一般情况、术前及术后1d、3d的氧化应激反应[超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)]、胃肠功能[胃动素(MTL)、胃泌素(GAS)、]、并发症及术后6个月的预后情况。结果研究组患者的手术时间(206.53±33.54)min,明显短于对照组的(254.39±36.87)min,治疗费用(8.52±1.60)万元,明显低于对照组的(9.07±1.58)万元,差异均有统计学意义(P<0.05);术后1d,研究组患者的GSH-Px、SOD、GAS、MTL水平分别为(104.69±17.24)U/mL、(92.27±10.328)U/mL、(57.39±7.21)ng/L、(110.28±10.79)ng/L,术后3d分别为(124.69±19.32)U/mL、(106.73±12.64)U/mL、(62.59±6.33)ng/L、(132.51±14.77)ng/L,均明显高于对照组术后1d的(92.88±15.37)U/mL、(83.51±9.36)U/mL、(51.53±6.45)ng/L、(96.55±11.86)ng/L,术后3d的(110.73±18.31)U/mL、(95.77±11.58)U/mL、(55.28±7.14)ng/L、(112.49±15.11)ng/L,差异均有统计学意义(P<0.05);术后1d、3d,研究组患者的MDA水平分别为(8.39±1.47)nmol/mL、(6.54±1.22)nmol/mL,明显低于对照组的(10.74±1.58)nmol/mL、(7.28±1.35)nmol/mL,差异均有统计学意义(P<0.05);研究组患者的吻合口瘘和喉返神经损伤发生率分别为2.63%、5.26%,明显低于对照组的14.86%、16.22%,差异均有统计学意义(P<0.05);术后6个月,两组患者转移、复发、病死发生率比较差异均无统计学意义(P>0.05)。结论全腔镜Ivor-Lewis术治疗中下段食管癌能缩短手术时间,减轻氧化应激反应,能促进术后胃肠功能恢复,且不会增加并发症、肿瘤转移、复发和死亡风险,但治疗费用高,会增加患者经济负担。 展开更多
关键词 食管癌 腔镜 ivor-lewis 胃肠功能 氧化应激 预后
下载PDF
胸腹腔镜下Ivor-lewis手术治疗Siewert Ⅱ型食管胃交界部腺癌的临床疗效
11
作者 李德冰 张克 梁少杰 《海南医学》 CAS 2023年第17期2484-2488,共5页
目的探究胸腹腔镜下Ivor-lewis手术治疗Siewert Ⅱ型食管胃交界部腺癌(AEGⅡ)患者的临床疗效。方法选取2020年1月至2022年1月河南科技大学第一附属医院收治的120例AEGⅡ患者纳入研究,采用随机数表法分为开胸组(实施开放手术)和微创组(... 目的探究胸腹腔镜下Ivor-lewis手术治疗Siewert Ⅱ型食管胃交界部腺癌(AEGⅡ)患者的临床疗效。方法选取2020年1月至2022年1月河南科技大学第一附属医院收治的120例AEGⅡ患者纳入研究,采用随机数表法分为开胸组(实施开放手术)和微创组(实施胸腹腔镜下Ivor-lewis手术)各60例。比较两组患者的手术相关指标、术后各时间视觉模拟量表(VAS)评分、手术前后细胞免疫功能[淋巴细胞CD3^(+)、CD4^(+)、CD8^(+)]、肿瘤标志物[抗原细胞角蛋白19片段抗原21-1(CYFRA21-1)、癌胚抗原(CEA)、糖类抗原199(CA199)],同时比较两组患者的并发症情况及术后1年复发情况。结果微创组患者的手术时间、清扫淋巴结数目分别为(239.58±42.35)min、(34.58±7.82)个,明显长(多)于开胸组的(195.46±40.37)min、(25.62±7.31)个,术中总出血量、胃管拔出时间和住院天数分别为(155.84±21.55)mL、(8.15±1.79)d、(12.29±2.15)d,明显少于开胸组的(194.72±25.74)m L、(10.39±1.84)d、(15.44±2.48)d,差异均有统计学意义(P<0.05);术后24 h、72 h,微创组患者的VAS评分分别为(5.94±1.24)分、(2.15±0.63)分,明显低于开胸组的(6.85±1.23)分、(3.44±0.74)分,差异均有统计学意义(P<0.05);微创组患者术后3 d的CD3^(+)、CD4^(+)水平分别为(49.57±2.98)%、(33.95±1.89)%,术后7 d分别为(53.29±3.17)%、(35.22±1.86)%,明显高于开胸组术后3 d的(46.38±3.21)%、(31.77±1.83)%和术后7 d的(51.83±2.95)%、(33.71±1.95)%,差异均有统计学意义(P<0.05);微创组患者术后3 d和7 d的CD8^(+)水平分别为(28.74±2.19)%、(26.92±1.49)%,明显低于开胸组的(30.25±2.04)%、(27.54±1.62)%,差异均有统计学意义(P<0.05);微创组患者术后6个月的CYFRA21-1、CEA、CA199水平分别为(2.38±0.26)ng/mL、(3.27±0.45)ng/mL、(27.83±2.19)U/mL,术后12个月分别为(2.45±0.32)ng/mL、(3.35±0.44)ng/mL、(28.57±2.21)U/mL,明显低于开胸组术后6个月的(2.53±0.29)ng/mL、(3.51±0.41)ng/mL、(29.01±1.98)U/mL和术后12个月的(2.60±0.35)ng/mL、(3.59±0.43)ng/mL、(29.54±2.29)U/mL,差异均有统计学意义(P<0.05);微创组患者术后并发症总发生率和术后1年复发率分别为8.33%、1.67%,略低于开胸组的18.33%、5.00%,但差异均无统计学意义(P>0.05)。结论胸腹腔镜下Ivor-lewis手术治疗AEGⅡ能优化手术指标,改善免疫功能,提高肿瘤细胞清除效果,减轻疼痛,促进术后早期快速恢复,抑制肿瘤细胞表达,均具有较好的短期疗效及安全性。 展开更多
关键词 胃腺癌 ivor-lewis手术 开放手术 胸腹腔镜 细胞免疫功能 临床疗效 安全性
下载PDF
食管癌Ivor-Lewis手术下胃食管吻合方式的最新进展
12
作者 付佳伟 缪巍 《临床医学进展》 2023年第6期9177-9181,共5页
目前,Ivor-Lewis手术仍然是治疗食管癌的最佳选择,其中最关键的部分在于胃食管吻合技术的发展。为了更好地实现这一目标,我们需要不断改进吻合方法,并对其进行归纳总结。无论是传统的手工吻合技术,还是先进的机械吻合技术,无论是线性吻... 目前,Ivor-Lewis手术仍然是治疗食管癌的最佳选择,其中最关键的部分在于胃食管吻合技术的发展。为了更好地实现这一目标,我们需要不断改进吻合方法,并对其进行归纳总结。无论是传统的手工吻合技术,还是先进的机械吻合技术,无论是线性吻合还是圆形吻合,其优劣都在影响术后吻合口并发症的发生。因此,有效的吻合技术不仅需要操作简便,更重要的是能够有效减少吻合口并发症的发生,而新型吻合技术也正在不断探索中。食管癌Ivor-Lewis手术之所以未完全使用,是因为目前缺乏较好的吻合方式,所以想要进行推广使用Ivor-Lewis手术,胃食管吻合方式则是以后的研究重点。肿瘤外科医生应在创新性吻合方式上进行更多的研究,在为患者构建更好的预后上不懈努力。 展开更多
关键词 食管癌 ivor-lewis手术 胃食管吻合 消化道重建
下载PDF
Ivor-Lewis术式与传统左开胸入路治疗食管胃交界腺癌的临床效果分析
13
作者 朱建福 张玉景 +4 位作者 周峰 肖海波 李森 何爱敏 张召辉 《中国医刊》 CAS 2023年第3期287-290,共4页
目的探讨Ivor-Lewis术式与传统左开胸入路治疗食管胃交界腺癌的临床效果。方法选取2015年1月至2020年10月徐州医科大学附属淮海医院陆军第七十一集团军医院和上海交通大学附属新华医院收治的食管胃交界腺癌患者88例,采用随机数表法分为... 目的探讨Ivor-Lewis术式与传统左开胸入路治疗食管胃交界腺癌的临床效果。方法选取2015年1月至2020年10月徐州医科大学附属淮海医院陆军第七十一集团军医院和上海交通大学附属新华医院收治的食管胃交界腺癌患者88例,采用随机数表法分为观察组(采用Ivor-Lewis术式治疗)和对照组(采用传统左开胸入路手术治疗),每组44例。比较两组患者的围术期指标、术中淋巴结清扫数、血清炎症因子水平、术后并发症发生情况及术后1年和2年的生存率。结果观察组术中出血量、术后第1天引流量、胸腔引流时间及胃管拔出时间均明显低于对照组,差异有显著性(P<0.05),而两组手术时间比较差异无显著性(P>0.05)。观察组术中清扫淋巴结总数及腹腔清扫淋巴结数均明显多于对照组(P<0.05),而胸腔清扫淋巴结数两组比较差异无显著性(P>0.05)。两组术前血清C反应蛋白(C-reactive protein,CRP)和白细胞介素-6(interleuking-6,IL-6)水平比较差异无显著性(P>0.05);术后两组CRP和IL-6水平均明显高于术前,且术后1d时观察组明显低于对照组(P<0.05),而术后7d时两组比较差异无显著性(P>0.05)。观察组术后并发症发生率(6.82%)与对照组(11.36%)比较差异无显著性(P>0.05)。两组术后1年及2年生存率比较差异无显著性(P>0.05)。结论采用Ivor-Lewis术式治疗食管胃交界腺癌可显著改善围术期指标,淋巴结清扫数更多,术后炎症反应较轻,值得临床应用。 展开更多
关键词 食管胃交界腺癌 ivor-lewis手术 传统左开胸入路 炎症因子 胸腔镜 腹腔镜
下载PDF
全腔镜Ivor-Lewis手术治疗中下段食管癌
14
作者 杨泽波 张松林 胡旭 《巴楚医学》 2023年第4期32-34,共3页
食管癌在我国发病率及死亡率均较高,外科手术是食管癌的主要治疗方法。经右胸腹两切口Ivor-Lewis手术是中下段食管癌的首选手术方式,不仅可保证根治手术的彻底性,吻合口瘘等并发症发生率也较低。经过不断技术改进,全腔镜的Ivor-Lewis手... 食管癌在我国发病率及死亡率均较高,外科手术是食管癌的主要治疗方法。经右胸腹两切口Ivor-Lewis手术是中下段食管癌的首选手术方式,不仅可保证根治手术的彻底性,吻合口瘘等并发症发生率也较低。经过不断技术改进,全腔镜的Ivor-Lewis手术现已发展成熟,围手术期效果良好。本文拟对全腔镜Ivor-Lewis手术具体操作步骤进行详细介绍,为基层临床医生提供借鉴。 展开更多
关键词 中下段食管癌 微创食管切除术 胸内吻合 吻合口瘘
下载PDF
胸腹腔镜Ivor-Lewis术与McKeown术治疗中下段食管癌的疗效比较
15
作者 熊照广 《保健医学研究与实践》 2023年第5期36-39,共4页
目的比较胸腹腔镜Ivor-Lewis术与McKeown术治疗中下段食管癌的疗效,以期为临床治疗提供参考。方法本研究选取2017年6月—2021年1月在河南省周口市人民医院就诊的109例食管癌患者为研究对象。采用随机数字表法,将患者分为McKeown组(n=47)... 目的比较胸腹腔镜Ivor-Lewis术与McKeown术治疗中下段食管癌的疗效,以期为临床治疗提供参考。方法本研究选取2017年6月—2021年1月在河南省周口市人民医院就诊的109例食管癌患者为研究对象。采用随机数字表法,将患者分为McKeown组(n=47)与Ivor-Lewis组(n=62)。Ivor-Lewis组患者采用Ivor-Lewi术治疗。McKeown组患者采用McKeown术治疗。比较2组患者手术时间、术中出血量、淋巴结清扫数量、术后进食时间、拔管时间以及住院时间;比较2组患者术前和术后7d的免疫功能指标,包括免疫球蛋白A(IgA)、免疫球蛋白M(IgM)及免疫球蛋白G(IgG)水平;比较2组患者术前和术后3个月的食管癌生活质量量表(QLQ-OES18)评分;比较2组患者术后至随访3个月时并发症发生情况。结果2组患者手术时间、淋巴结清扫数量以及术后进食时间比较,差异无统计学意义(P>0.05)。Iovr-Lewis组患者术中出血量少于McKeown组,拔管时间和住院时间短于McKeown组,差异均有统计学意义(P<0.05)。术前,2组患者IgA、IgM及IgG水平比较,差异无统计学意义(P>0.05)。术后7d,Ivor-Lewis组患者IgA、IgM及IgG水平均高于McKeown组,差异均有统计学意义(P<0.05)。术前,2组患者QLQ-OES18中吞咽困难、进食、反流、疼痛评分比较,差异无统计学意义(P>0.05)。术后3个月,2组患者QLQ-OES18中吞咽困难、进食、反流、疼痛评分均低于术前(P<0.05)。2组患者并发症发生率比较,差异无统计学意义(P>0.05)。结论Ivor-Lewis术和McKeown术对中下段食管癌的疗效相当,但Ivor-Lewis术的损伤更小,能更好地保护免疫功能,值得临床推广应用。 展开更多
关键词 腹腔镜 ivor-lewis McKeown术 食管癌
下载PDF
全腔镜Ivor-Lewis术在食管癌中的疗效及对疼痛指标的影响
16
作者 王林 刘光义 单体海 《中国医学创新》 CAS 2023年第28期9-13,共5页
目的:探讨全腔镜经腹胸二切口食管癌根治胸内吻合术(Ivor-Lewis术)在食管癌中的疗效及对疼痛指标的影响。方法:选取2018年1月—2021年1月潍坊市心脏病医院收治的101例食管癌患者,使用随机数字表法将其分为观察组(51例)和对照组(50例)。... 目的:探讨全腔镜经腹胸二切口食管癌根治胸内吻合术(Ivor-Lewis术)在食管癌中的疗效及对疼痛指标的影响。方法:选取2018年1月—2021年1月潍坊市心脏病医院收治的101例食管癌患者,使用随机数字表法将其分为观察组(51例)和对照组(50例)。对照组接受全腔镜经颈胸腹三切口食管癌根治颈部吻合术(McKeown术)治疗,观察组接受全腔镜Ivor-Lewis术治疗,对比两组的手术相关指标、疼痛指标、肺功能指标、肿瘤标志物指标及并发症发生率。结果:观察组手术时间短于对照组,术中出血量少于对照组(P<0.05);两组的淋巴结清扫数、引流管留置时间、术后住院时间相较差异均无统计学意义(P>0.05)。术前,两组P物质(SP)、神经肽Y(NPY)、5-羟色胺(5-HT)、去甲肾上腺素(NE)及钾离子(K^(+))水平相较差异均无统计学意义(P>0.05);术后,两组上述指标均上升,观察组均低于对照组(P<0.05)。术前,两组第1秒用力呼气容积(FEV_(1))占用力肺活量(FVC)的百分比、FEV_(1)占预计值百分比(FEV_(1)%pred)、动脉血氧分压(PaO_(2))、动脉血氧饱和度(SaO_(2))水平相较差异均无统计学意义(P>0.05);术后,两组上述指标均降低,观察组均高于对照组(P<0.05)。术前,两组转录因子YY1(YY1)、可溶型MHC-Ⅰ类链相关蛋白A(sMICA)及细胞角蛋白19片段抗原21-1(Cyfra21-1)水平相较差异均无统计学意义(P>0.05);术后,两组上述指标均降低,观察组均低于对照组(P<0.05)。观察组的并发症发生率(1.96%)低于对照组(12.00%)(P<0.05)。结论:全腔镜Ivor-Lewis术可降低食管癌患者的术后疼痛程度,减少肺功能损伤,减缓肿瘤发展进程,减少术后并发症,安全有效。 展开更多
关键词 食管癌 ivor-lewis McKeown术 疼痛 肺功能 肿瘤标志物
下载PDF
改良喉返神经旁淋巴结清扫联合改良Ivor-Lewis术治疗食管癌的临床效果研究
17
作者 胡国梁 任丹 +1 位作者 涂启敏 姚元波 《中国肿瘤外科杂志》 CAS 2023年第5期492-496,共5页
目的探讨改良喉返神经旁淋巴结(RLNLN)清扫联合改良Ivor-Lewis术对食管癌患者的疗效及对糖类抗原19-9(CA19-9)和血管内皮生长因子(VEGF)的影响。方法选取武汉大学恩施临床学院收治的86例食管癌患者,根据术中RLNLN清扫方式的差异分为两组... 目的探讨改良喉返神经旁淋巴结(RLNLN)清扫联合改良Ivor-Lewis术对食管癌患者的疗效及对糖类抗原19-9(CA19-9)和血管内皮生长因子(VEGF)的影响。方法选取武汉大学恩施临床学院收治的86例食管癌患者,根据术中RLNLN清扫方式的差异分为两组:研究组40例,采用改良RLNLN清扫联合改良Ivor-Lewis术治疗;对照组46例,采用传统RLNLN清扫联合改良Ivor-Lewis术治疗。比较两组患者的临床疗效及血清VEGF和CA19-9水平差异。结果研究组的总有效率高于对照组(95.0%vs.71.7%,P<0.05);两组的手术时间、术中出血量、住院时间及术后并发症发生率比较差异无统计学意义(P>0.05);研究组的RLNLN清扫数目大于对照组(P<0.05);与术前相比,两组术后血清VEGF和CA19-9水平均降低(P<0.05),且研究组术后血清VEGF和CA19-9水平均低于对照组(P<0.05)。术后1年,两组患者存活情况差异无统计学意义(P>0.05),但研究组的复发率低于对照组(5.00%vs.19.57%,P=0.044)。结论改良RLNLN清扫联合改良Ivor-Lewis术对食管癌的疗效更佳,同时还可提高RLNLN的清扫效率并减轻肿瘤负荷,最终降低患者的复发率,值得临床推广应用。 展开更多
关键词 食管癌 改良喉返神经旁淋巴结清扫 改良ivor-lewis 疗效 预后
下载PDF
The clinical application and advancement of robot-assisted McKeown minimally invasive esophagectomy for esophageal cancer
18
作者 Raojun Luo Yiming Li +4 位作者 Xiumin Han Yunzheng Wang Zhengfu He Peijian Yan Ziyi Zhu 《Laparoscopic, Endoscopic and Robotic Surgery》 2024年第1期6-10,共5页
Robotic surgery systems,as emerging minimally invasive approaches,have been increasingly applied for the treatment of esophageal cancer because they provide a high-definition three-dimensional surgical view and mechan... Robotic surgery systems,as emerging minimally invasive approaches,have been increasingly applied for the treatment of esophageal cancer because they provide a high-definition three-dimensional surgical view and mechanical rotating arms that surpass the limitations of human hands,greatly enhancing the accuracy and flexibility of surgical methods.Robot-assisted McKeown esophagectomy(RAME),a common type of robotic esophagectomy,has been gradually implemented with the aim of reducing postoperative complications,improving postoperative recovery and achieving better long-term survival.Multiple centers worldwide have reported and summarized their experiences with the RAME,and some have also discussed and analyzed its perioperative effects and survival prognosis compared with those of video-assisted minimally invasive esophagectomy.Compared to traditional surgery,the RAME has significant advantages in terms of lymph node dissection although there seems to be no difference in overall survival or disease-free survival.With the continuous advancement of technology and the development of robotic technology,further development and innovation are expected in the RAME field.This review elaborates on the prospects of the application and advancement of the RAME to provide a useful reference for clinical practice. 展开更多
关键词 Esophageal cancer Minimally invasive esophagectomy Robot-assisted McKeown esophagectomy Lymph node dissection
下载PDF
微创Ivor-Lewis食管切除术治疗SiewertⅠ型食管胃交界部腺癌的效果研究
19
作者 董威 武凌云 《当代医药论丛》 2023年第3期100-103,共4页
目的:研究微创Ivor-Lewis食管切除术治疗SiewertⅠ型食管胃交界部腺癌的效果。方法:从2020年1月—2020年12月期间在秭归县中医医院接受手术治疗的SiewertⅠ型食管胃交界部腺癌患者中筛选研究对象,共获得研究对象80例,随机分入对照组或... 目的:研究微创Ivor-Lewis食管切除术治疗SiewertⅠ型食管胃交界部腺癌的效果。方法:从2020年1月—2020年12月期间在秭归县中医医院接受手术治疗的SiewertⅠ型食管胃交界部腺癌患者中筛选研究对象,共获得研究对象80例,随机分入对照组或观察组。对照组采取传统的左胸食管切除术治疗,观察组采取微创Ivor-Lewis食管切除术治疗。对比术中临床指标、术后康复指标、并发症发生情况、临床转移和复发情况。结果:相较于对照组,观察组术中出血量少,正常食管切除长度长,淋巴结清扫总数、胸腔淋巴结清扫数、腹腔淋巴结清扫数多,手术时间长,术后第一天胸腔引流量少,胸腔引流时间、术后排气时间、术后住院时间短,P<0.05。两组的术后并发症总发生率无显著差异,P>0.05。两组的肝转移发生率、肺转移发生率、腹膜后淋巴结转移发生率、纵膈淋巴结转移发生率和转移总发生率均无显著差异,P>0.05。两组临床复发情况相比,吻合口复发发生率无显著差异,P>0.05。结论:微创Ivor-Lewis食管切除术治疗SiewertⅠ型食管胃交界部腺癌虽然手术时间较长,但能减少术中出血量,比较彻底地清扫淋巴结,促进患者术后快速康复,且安全性和远期疗效均良好。 展开更多
关键词 微创ivor-lewis食管切除术 SiewertⅠ型 食管胃交界部腺癌
下载PDF
Cost burden following esophagectomy:A single centre observational study
20
作者 Vered Buchholz Dong Kyu Lee +7 位作者 David S Liu Ahmad Aly Stephen A Barnett Riley Hazard Peter Le Benjamin Kioussis Vijayaragavan Muralidharan Laurence Weinberg 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第7期2255-2269,共15页
BACKGROUND Cost analyses of patients undergoing esophagectomy is valuable for identifying modifiable expenditure drivers to target and curtail costs while improving the quality of care.We aimed to define the cost-comp... BACKGROUND Cost analyses of patients undergoing esophagectomy is valuable for identifying modifiable expenditure drivers to target and curtail costs while improving the quality of care.We aimed to define the cost-complication relationship after esophagectomy and delineate the incremental contributions to costs.AIM To assess the relationship between the hospital costs and potential cost drivers post esophagectomy and investigate the relationship between the cost-driving variables(predicting variables)and hospital costs(dependent variable).METHODS In this retrospective single center study,the severity of complications was graded using the Clavien-Dindo(CD)classification system.Key esophagectomy complications were categorized and defined according to consensus guidelines.Raw costing data included the in-hospital costs of the index admission and any unplanned admission within 30 postoperative days.We used correlation analysis to assess the relationship between key clinical variables and hospital costs(in United States dollars)to identify cost drivers.A mediation model was used to investigate the relationship between these variables and hospital costs.RESULTS A total of 110 patients underwent primary esophageal resection.The median admission cost was $47822.7(interquartile range:35670.2-68214.0).The total effects on costs were $13593.9(95%CI:10187.1-17000.8,P<0.001)for each increase in CD severity grade,$4781(95%CI:3772.7-5789.3,P<0.001)for each increase in the number of complications,and $42552.2(95%CI:8309-76795.4,P=0.015)if a key esophagectomy complication developed.Key esophagectomy complications drove the costs directly by $11415.7(95%CI:992.5-21838.9,P=0.032).CONCLUSION The severity and number of complications,and the development of key esophagectomy complications significantly contributed to total hospital costs.Continuous institutional initiatives and strategies are needed to enhance patient outcomes and minimize costs. 展开更多
关键词 ANESTHESIA esophagectomy COMPLICATIONS Cancer Surgery
下载PDF
上一页 1 2 58 下一页 到第
使用帮助 返回顶部